Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0OS7K
|
||||
| Former ID |
DNCL002501
|
||||
| Drug Name |
EGEN-001
|
||||
| Indication | Fallopian tube cancer; Peritoneal cancer; Ovarian cancer [ICD9: 140-229, 183.2, 221.0, 183; ICD10:C57, D28, C56] | Phase 2 | [523029] | ||
| Company |
EGEN
|
||||
| Target and Pathway | |||||
| Target(s) | Interleukin-12 ligand | Target Info | Modulator | [550403] | |
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Toll-like receptor signaling pathway | |||||
| RIG-I-like receptor signaling pathway | |||||
| Jak-STAT signaling pathway | |||||
| Type I diabetes mellitus | |||||
| Pertussis | |||||
| Legionellosis | |||||
| Leishmaniasis | |||||
| Chagas disease (American trypanosomiasis) | |||||
| African trypanosomiasis | |||||
| Malaria | |||||
| Toxoplasmosis | |||||
| Amoebiasis | |||||
| Tuberculosis | |||||
| Measles | |||||
| Influenza A | |||||
| Herpes simplex infection | |||||
| Inflammatory bowel disease (IBD) | |||||
| Allograft rejection | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.